Sino Biopharmaceutical Financial Overview
Sino Biopharmaceutical's market cap is currently €12.62B. The company's EPS TTM is €0.022745744; its P/E ratio is 27.29; Sino Biopharmaceutical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is €0.01. See an overview of income statement, balance sheet, and cash flow financials.
